Suflit Sustained-Release Tablets 300 mg (Sarpogrelate Hydrochloride)

Adult dose

Administer Sarpogrelate Hydrochloride sustained-release 300 mg, orally once daily after meals. This medication should be taken whole without chewing or crushing.

This medication should not be used in patients with bleeding as it may increase the risk of bleeding. Women who are pregnant or may become pregnant should avoid use as it may affect the fetus. Patients who are menstruating or have a tendency to bleed should use this medication with caution as the risk of bleeding may increase. Patients taking anticoagulants or antiplatelet agents may have an increased risk of bleeding, so caution is advised when using together. Patients with severe renal impairment should be cautious as this may affect drug excretion. Elderly patients may experience adverse reactions more readily and should use it with care. During the use of this medication, various adverse reactions, including urticaria, dyspepsia, headache, and cough, may occur; if symptoms arise, consultation with a healthcare professional is recommended. It is important to check for adverse reactions through regular tests such as blood tests. Pregnant or lactating women are advised not to take this medication; if unavoidable, breastfeeding should be avoided. Safety for children has not been established, and there is no experience in usage, so it is not recommended for children. This medication should be kept out of reach of children, and transferring it to other containers is not advisable as it may impair quality.

Serious side effects

Urticaria, bleeding tendency (gastrointestinal bleeding, cerebral hemorrhage, subcutaneous bleeding, etc.), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, respiratory distress, severe allergic reactions, severe skin adverse reactions, serious neurological symptoms, severe edema, or urinary abnormalities

Mild side effects

• Pharyngitis
• conjunctivitis
• upper respiratory tract infection
• dyspepsia
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• reduced appetite

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The appropriate storage temperature is between 1 degree and 30 degrees Celsius at room temperature. Storing in this manner can help maintain the effectiveness of the medication.

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle